Recent studies have suggested that sonic Hedgehog (Shh) signaling pathway is aberrantly activated in cancer stem cells (CSCs). A seven-herb Chinese medicinal formula composed of Amorphophallus rivieri Durieu, Oldenlandia diffusa (Wild) Roxb, Scutellaria barbata D. Don, Gynostemma pentaphyllum (Thunb.) Mak and Amomum cardamomum L, i.e.
Qingyihuaji (QYHJ) formula, has been shown to inhibit proliferation of pancreatic CSCs by inhibiting Shh signaling pathway and thereby prolong the overall survival of
pancreatic cancer patients. Mass spectrometry analysis revealed that
baicalein is one of the major compounds of QYHJ formula. The objective of this study was to investigate the role of Shh pathway in
pancreatic cancer and to examine the molecular mechanisms of
baicalein involved in
pancreatic cancer treatment. We examined the effects of
baicalein on pancreatic CSCs both in vivo and in vitro. The results indicated that
baicalein attenuated the pluripotency of pancreatic CSCs. Then, we investigated the underlying mechanism and found that nuclear
transcription factors, such as Sox-2 and Oct-4 as well as members in Shh signaling pathway, e.g. SHH, SMO, and Gli-2, were downregulated after
baicalein treatment. Furthermore, silencing Gli-2 expression by
small interfering RNA decreased Sox-2 expression and blocked the inhibitory effects of
baicalein, suggesting that the effects of
baicalein may be mediated through inhibition of Shh pathway. Our results suggested that
baicalein, an active compound in QYHJ formula, could suppress the self-renewal of pancreatic CSCs through inhibition of Shh signaling pathway.